Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

DTRA Chem-Bio BAA Contract Awards

by Global Biodefense Staff
October 1, 2014

Defense Threat Reduction Agency - Counter CBRNEThe Defense Threat Reduction Agency has recently identified all contracts that were awarded under the Chemical and Biological Technologies Department FY 2014 Program Build Broad Agency Announcement: HDTRA1-14-CHEM-BIO-BAA.

The following organizations were awarded funding:

  • Clarkson University: Characterization of Particle Interaction with Non-Ideal Surface: Role of particle properties, surface roughness, and humidity $930,568 (January 2014)
  • University of South Alabama: Antigenically Defined Vaccines for Immunization $1,728,535 (Feb 2014)
  • Exelis, Inc: Chapter 8 Structures, Site Characteristics $739,174 (March 2014)
  • Texas A&M: Vaccine Candidate for Q Fever $4,556,064 (April 2014)
  • Exelis, Inc: Extending DTRIAC STARS for CB-1 $535,866 (April 2014)
  • Applied Research Associates: CB-1 Consequence Assessment $729,627 (April 2014)
  • University of Texas at Austin: Surety BioEvent App $2,771,939 (May 2014)
  • Leidos: Global Modeling for Influenze Dynamics $3,479,364 (June 2014)
  • University of Texas at San Antonio: Development and Characterization of a Novel Vaccine against Tularemia $4,792,055 (June 2014)
  • Mapp Biopharmaceuticals: Development of a Broad-Spectrum Monoclonal Cocktail for Prevention of VEEV, WEEV, and EEEV $7,545,000 (June 2014)
  • Tulane University: A Broad Spectrum OMV Vaccine against Aerosolized B. Pseudomallei and B. mallei $400,451 (July 2014)
  • Evolva SA: The First Oral Antibiotic for the Treatment of Acute Melioidosis and Select Agents $15,110,274 (Aug 2014)
  • Kentucky Bioprocessing: Nicotiana rBuCHe – A Cost Effective Countermeasure $3,510,263.47 (Aug 2014)

Source: FBO.gov

Tags: AwardsBAADefense Threat Reduction Agency

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC